Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Profire Energy | PFIE | Mar 14, 2025 | 2.54 | 0.00 |
Profound Medical | PROF | Mar 14, 2025 | 6.95 | -0.71 |
ProFrac A | ACDC | Mar 14, 2025 | 7.27 | +0.97 |
PROG | PRG | Mar 14, 2025 | 26.71 | +2.02 |
Progress Software | PRGS | Mar 14, 2025 | 55.23 | +2.87 |
Progressive | PGR | Mar 14, 2025 | 283.69 | +1.54 |
Progyny | PGNY | Mar 14, 2025 | 20.36 | +2.62 |
ProKidney | PROK | Mar 14, 2025 | 0.98 | +3.24 |
Prologis | PLD | Mar 14, 2025 | 111.89 | +1.39 |
ProMIS Neurosciences | PMN | Mar 14, 2025 | 0.77 | -2.78 |
ProPetro | PUMP | Mar 14, 2025 | 6.88 | +3.15 |
ProPhase Labs | PRPH | Mar 14, 2025 | 0.39 | -7.78 |
ProQR Therapeutics | PRQR | Mar 14, 2025 | 1.69 | -2.87 |
PROS | PRO | Mar 14, 2025 | 20.61 | +2.33 |
ProShares Bitcoin Strategy ETF | BITO | Mar 14, 2025 | 18.87 | +5.71 |
Proshares Ultra FTSE Europe | UPV | Mar 14, 2025 | 69.90 | +4.03 |
ProShares UltraShort Bloomberg Natural Gas | KOLD | Mar 14, 2025 | 19.70 | -2.67 |
Proshares Ultrashort FTSE Europe | EPV | Mar 14, 2025 | 32.06 | -4.07 |
Prospect Capital | PSEC | Mar 14, 2025 | 4.29 | +2.39 |
Prospect Capital A Pref | PSEC-A | Mar 14, 2025 | 16.24 | +0.19 |
Prosperity Bancshares | PB | Mar 14, 2025 | 71.06 | +2.54 |
Protagenic Therapeutics | PTIX | Mar 14, 2025 | 0.26 | -4.38 |
Protagonist Therapeutics | PTGX | Mar 14, 2025 | 54.78 | -0.22 |
Protalix Bio Therapeutics | PLX | Mar 14, 2025 | 2.24 | +3.23 |
Protara Therapeutics | TARA | Mar 14, 2025 | 4.31 | +7.21 |
Prothena | PRTA | Mar 14, 2025 | 13.74 | -2.35 |
Proto Labs | PRLB | Mar 14, 2025 | 36.55 | +2.30 |
Provident Bancorp | PVBC | Mar 14, 2025 | 11.52 | +2.13 |
Provident Financial | PROV | Mar 14, 2025 | 14.15 | +0.04 |
Provident Financial Services | PFS | Mar 14, 2025 | 17.15 | +2.94 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.